RCE-ESMO-ESO Training Course for Rare Cancer Patient Advocates 2021 Online Training

Programme and registration

The Rare Cancer Patient Advocates Training Course 2021 will virtually take place over multiple days, from January 14 to January 21. Our participants will be given the opportunity to attend all the sessions.

Throughout several sessions the participants will be informed about the latest update on Rare Cancers on the EU Agenda as well as will be introduced to the ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancer training (16-17 January). Moreover, the attendees will have the opportunity to participate to the Patient Cafés which will be focused on COVID-19 and rare cancers. This session aims to highlight the challenges faced by individual rare cancer patients, patient organisations, and physicians. Lastly, the final session will be split into three different sub-sessions dedicated to patient involvement in clinical research. The sub-sessions will take place between 19 January and 21 January, and they will be centred on patient involvement in clinical trials, patient involvement in clinical registries, and patient involvement in tumour banks.

Please find here the preliminary RCE-ESMO-ESO Training Course for Rare Cancer Patient Advocates 2021 programme.

To register to the different sessions, please find below the registration links.

Session 1: Rare Cancers on the EU Agenda

Register for this session here

Session 2: COVID-19 and cancer: lessons learned, pathway for the future

Register for this session here

Session 3: PATIENT INVOLVEMENT IN CLINICAL RESEARCH is composed of three different sub-sessions of one hour each.

The registration links for the sub-sessions are below reported:  

Patient involvement in clinical trials

Register for this session here

Patient involvement in clinical registries

Register for this session here

Patient involvement in tumour banks

Register for this session here

Like in the previous editions the Rare Cancer Patient Advocates Training Course 2021 will be organised in synergy with the 5th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers.

For any clarification requests please contact the RCE Secretariat:  rarecancerseurope@esmo.org